Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib. - Dagogo-Jack I; Manoogian A; Jessop N; Georgantas NZ; Fintelmann FJ; Farahani A; Digumarthy SR; Price MC; Folch EE; Keyes CM; Do A; Peterson JL; et al. (JCO oncology practice, 2023)